Launching new businesses in the pharmaceutical and medical, and environment and energy, sectors
First written in FY2021. 2 of 3 entries say "Advanced", first in FY2024. Latest entry: FY2025.
2 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「Under NEDO’s “Bio-Manufacturing Revolution Promotion Project,” for which our company was selected as the representative company, the “Research and Development for the Social Implementation of Cultivated Beef” project is pursuing the development of mass-cultivation technology for bovine cells and the establishment of rules for the social implementation of cultivated beef.」
Mass cultivation and bio-manufacturing, new business areas, progressed through NEDO selection to technology development and rulemaking for social implementation. - FY2024AdvancedAnnual report
「The “Research and Development for the Social Implementation of Cultivated Beef” project was selected for NEDO’s “Bio-Manufacturing Revolution Promotion Project,” with our company as the representative company. In cooperation with the participating lead companies and relevant academic institutions, we are working not only on technology development but also on establishing rules for social implementation.」
The policy for new businesses in pharmaceuticals and healthcare, and the environment and energy, progressed into specific commercialization activities, including the social implementation of cultivated beef and contract cultivation and processing. - FY2021First statedAnnual report
「We will develop our future business portfolio by launching new businesses, such as mass cultivation and medical devices, in the pharmaceuticals and healthcare, and environment and energy fields, outside the trajectory of our existing businesses.」
The company presented the launch of new businesses outside the extension of its existing operations, including mass cultivation and medical devices, as a new initiative.